Avidigo services

White glove Cell Avidity services
Full-service contract research from experimental design to data report based on Cell Avidity measurements at high throughput.

Part of:

Cell avidity

Revolutionize binding for the future of cell & antibody therapeutics

Visit Cell Avidity page
The perfect Cell Avidity pilot study and a potential stepping stone to an Avidion
Make use of an expert team, from catered experimental design to data interpretation
Gain access to Cell Avidity data within a rapid timeframe

Typical timeframe

What's powering my experiments?

Avidion

The next generation Cell Avidity platform
With its high throughput capabilities, easy to use workflow and broad set of applications, our Avidigo services exclusively use our Avidion technology.
Discover Avidion
Key content

Discover all the details

Avidigo Service Brochure
Avidigo Service Brochure
Brochure
The latest all-in-one overview of our Avidigo solution.
Brochure

Let’s get in touch

Our team is standing by to help you
Contact us

Publications

Understand the key insights by reading up on our latest publications

View all
Technical note:
Filter CA shows 3 items
There is a hidden collection to add multiple authors to this publication.
This section is hidden when emtpy.
To keep everything visible here, that is being done outside the webflow designer from within Slater.
Text Link

Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinoma

Chaturantabut et al.,
2025
J. Clin. Investigation
Author Empty
Antibody Therapy
Publication
Text Link

Rational Chemical and Genetic Modifications Enhance Avidity and Function of CD70-Directed CAR T Cells for Myeloid Leukemia

Leick, M.B. et al.,
2022
Cancer Cell
Author Empty
Cell Therapy
Publication

Relevant resources

Learn as much as you can by reading up on our application notes or marathoning our webinars.

View all
Technical note:
Filter CA and show 4 Latest
This shows the most recent card of each resource type filtered on Business Unit CA.
Webinar, Scientific update, Whitepaper,  Application note, Brochure.
We only show 4 and we have 6 types so the 2 older ones are hidden.

In design only 1 is shown, but the rest will be loaded when published.
Button Text
Improving CAR-T immunotherapy for lymphoma by fine-tuning avidity

Improving CAR-T immunotherapy for lymphoma by fine-tuning avidity

Webinar
July 16, 2024
01-01-20

Commercial CAR-T therapies still suffer from severe limitations, as majority of patients fail to achieve complete response and ultimately relapse.

Watch this Webinar to discover Prof. Marco Ruella’s team have adopted a novel CAR-T avidity screening method to improve safety and exhaustion profile, leading to 100% clinical response in a phase I trial.

Text Link
Enhancing efficacy against clear cell renal cell carcinoma through format-tuning of bispecific T cell engagers

Enhancing efficacy against clear cell renal cell carcinoma through format-tuning of bispecific T cell engagers

Scientific update
January 29, 2025
01-01-20

Cell Avidity: a key to accelerate IND filing in cell therapy drug development

Cell Avidity: a key to accelerate IND filing in cell therapy drug development

Whitepaper
July 1, 2023
01-01-20

Cell Avidity measures true binding of biparatopic antibodies

Cell Avidity measures true binding of biparatopic antibodies

Application note
April 23, 2025
01-01-20

Mechanistic issues limit the effectiveness of many current cancer-targeting antibody therapies, with monospecific antibodies often hindered by receptor dimerization and activation. Biparatopic antibodies, which bind to two unique non-overlapping epitopes, offer a promising solution with stronger binding, more potent antagonism, and higher specificity.

Avidigo Service Brochure

Avidigo Service Brochure

Brochure
May 1, 2025
01-01-20

Connect with us

Stop by at a conference or user event, or tune in for a live webinar!

View all
SITC 2025

SITC 2025

Conference
April 22, 2025
01-01-20

CAR-TCR Summit 2025

CAR-TCR Summit 2025

Conference
April 22, 2025
01-01-20

CICON 2025

CICON 2025

Conference
April 22, 2025
01-01-20